NCT06822972
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Duke University Health System Durham, North Carolina, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,641 public trials
502 recruiting studies
Multiple Myeloma trial results
Recruiting
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
NCT05208307
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT07493135
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Beijing GoBroad Boren Hospital Beijing, China
- The second affiliated hospital of Chongqing medical university Chongqing, China
- Renji Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China
- Zhengzhou Yihe Hospital Zhengzhou, China
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Yale New Haven Hospital-Smilow Cancer Center New Haven, Connecticut, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT05272826
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- NL Health Services St. John's, Newfoundland and Labrador, Canada
- QEII Health Science Centre Halifax, Nova Scotia, Canada
- London Health Sciences Centre London, Ontario, Canada
NCT07479979
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
Recruiting
Elranatamab in R/R Multiple Myeloma
NCT06138275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
Recruiting
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
NCT07075185
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease, +24 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford University Palo Alto, California, United States
- UCSF San Francisco, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
NCT05652335
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- City of Hope Duarte, California, United States
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
- University of California San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
NCT06375044
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Dana Farber Cancer institution Boston, Massachusetts, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States